help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jöhren, O.
Right arrow Articles by Dominiak, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jöhren, O.
Right arrow Articles by Dominiak, P.
Endocrinology Vol. 144, No. 4 1219-1225
Copyright © 2003 by The Endocrine Society


ARTICLE

Gonadal Steroids Differentially Regulate the Messenger Ribonucleic Acid Expression of Pituitary Orexin Type 1 Receptors and Adrenal Orexin Type 2 Receptors

Olaf Jöhren, Norbert Brüggemann, Andreas Dendorfer and Peter Dominiak

Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Lübeck, D-23538 Lübeck, Germany

Address all correspondence and requests for reprints to: Olaf Jöhren, Ph.D., Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany. E-mail: Joehren{at}medinf.mu-luebeck.de.

Hypothalamic prepro-orexin as well as pituitary and adrenal orexin receptors are gender-specifically expressed. To assess the regulation by gonadal steroids, we investigated the effect of 17ß-estradiol in female and of testosterone in male rats on prepro-orexin and orexin receptor mRNA expression. Rats were either sham-operated or gonadectomized and subsequently treated with placebo, 17ß-estradiol, or testosterone for 21 d. Tissue mRNA levels of prepro-orexin, orexin type-1 (OX1), and orexin type-2 (OX2) receptors were measured using quantitative real-time RT-PCR.

In female rats, pituitary OX1 receptor mRNA levels were increased 12-fold after ovariectomy compared with sham- operated rats. The increase of pituitary OX1 receptor mRNA was inhibited by treatment with 17ß-estradiol. Adrenal mRNA levels of OX2 receptors in ovariectomized rats were increased 2-fold compared with sham-operated rats and were also reduced by treatment with 17ß-estradiol. In male rats, orchidectomy increased the mRNA levels of pituitary OX1 receptors compared with sham-operated rats. In contrast, adrenal OX2 receptor mRNA was reduced after orchidectomy. Testosterone treatment reversed the effect of orchidectomy on pituitary OX1 and adrenal OX2 receptors. In the hypothalamus, no differences were found in the mRNA levels of prepro-orexin, OX1, and OX2 receptors between sham-operated, placebo-treated, and steroid-treated female or male rats.

Our results indicate that gonadal steroids differentially regulate pituitary OX1 receptors and adrenal OX2 receptors in male and female rats and may contribute to specific sex- dependent neuroendocrine and endocrine actions of orexins.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Silveyra, V. Lux-Lantos, and C. Libertun
Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E977 - E985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Silveyra, P. N. Catalano, V. Lux-Lantos, and C. Libertun
Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E820 - E828.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Voisin, A. E. Firar, V. Avondo, and M. Laburthe
Orexin-Induced Apoptosis: The Key Role of the Seven-Transmembrane Domain Orexin Type 2 Receptor
Endocrinology, October 1, 2006; 147(10): 4977 - 4984.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer
Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. L. Barreiro, R. Pineda, F. Gaytan, M. Archanco, M. A. Burrell, J. M. Castellano, H. Hakovirta, M. Nurmio, L. Pinilla, E. Aguilar, et al.
Pattern of Orexin Expression and Direct Biological Actions of Orexin-A in Rat Testis
Endocrinology, December 1, 2005; 146(12): 5164 - 5175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Karteris, R. J. Machado, J. Chen, S. Zervou, E. W. Hillhouse, and H. S. Randeva
Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1089 - E1100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Karteris, J. Chen, and H. S. Randeva
Expression of Human Prepro-Orexin and Signaling Characteristics of Orexin Receptors in the Male Reproductive System
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1957 - 1962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society